Loratidine/pseudoephedrine for nasal symptoms in seasonal allergic rhinitis: A double-blind, placebo-controlled study

Ear, Nose and Throat Journal

Volumn 79, Issue 4, 2000, Pages 254-267

  McFadden, Edith A ^a   Gungor, Anil ^b   Ng, Bernard ^c   Mamikoglu, Bülent ^d   Moinuddin, Rizwan ^a   Corey, Jacquelynne ^a,e  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Metro Manila and Batangas   (Philippines)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LORATADINE; PSEUDOEPHEDRINE; ANTIALLERGIC AGENT; EPHEDRINE; HISTAMINE H1 RECEPTOR ANTAGONIST; VASOCONSTRICTOR AGENT;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ENDOSCOPY; FEMALE; HUMAN; MALE; NOSE CONGESTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; RHINOMETRY; SCORING SYSTEM; DRUG ADMINISTRATION; DRUG COMBINATION; HAY FEVER; MIDDLE AGED; PATIENT SATISFACTION; PHOTOGRAPHY; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

ADULT; ANTI-ALLERGIC AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; ENDOSCOPY; EPHEDRINE; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; LORATADINE; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHOTOGRAPHY; QUALITY OF LIFE; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 0034171184     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556130007900410     Document Type: Article

References (16)

1. Juniper EF, Guyatt GH, Andersson B, Ferrie PJ. Comparison of powder and aerosolized budesomde in perennial rhinitis: Validation of rhinitis quality of life questionnaire Ann Allergy 1993;70:225-30
2. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: Development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994;93:413-23.
3. Tarnasky PR, Van Arsdel PP Jr. Antihistamine therapy in allergic rhinitis J Fam Pract 1990;30:71-80.
4. Dockhom RJ, Bergner A, Connell JT, et al. Safety and efficacy of loratadine (Sch-29851). A new non-sedating antihistamine in seasonal allergic rhinitis. Ann Allergy 1987;58:407-11.
5. Bronsky E, Boggs P, Findlay S, et al. Comparative efficacy and safety of a once-daily loratadine-pseudoephedrme combination versus its components alone and placebo in the management of seasonal allergic rhinitis. J Allergy Clin Immunol 1995;96:139-47
6. Tandy JR, Mabry RL, Mabry CS. Correlation of modified radioallergosorbent test scores and skin test results. Otolarynsol Head Neck Surg 1996;115:42-5
7. Hilberg O, Jackson AC, Swift DL, Pedersen OF. Acoustic rhinometry: Evaluation of nasal cavity geometry by acoustic reflection J Appl Physiol 1989;66:295-303.
8. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis Clin Exp Allergy 1991;21 77-83.
9. Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol 1996;98:843-5.
10. Lai VW, Corey JP. The objective assessment of nasal patency. Ear Nose Throat J 1993,72 395-6, 399-400.
11. Grymer LF, Hilberg O, Pedersen OF. Rasmussen TR Acoustic rhinometry: Values from adults with subjective normal nasal patency. Rhinology 1991;29:35-47.
12. Roithmann R, Cole P, Chapnik J, et al Acoustic rhinometry, rhinomanometry, and the sensation of nasal patency A correlative study. J Otolaryngol 1994;23:454-8.
13. Watson WT, Roberts, JR, Becker AB, et al. Nasal patency in children with allergic rhinitis: Correlation of objective and subjective assessments Ann Allergy Asthma Immunol 1995;74 237-40
14. Zedahs D, Dolen WK, Glover GC, et al. Evaluation of nasal patency by fiberoptic rhinoscopy. J Allergy Clin Immunol 1989;83:973-8.
15. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important chance in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 1994;47:81-7
16. Guyatt GH, Townsend M, Berman LB, Keller JL. A comparison of Likert and visual analogue scales for measuring change in function. J Chron Dis 1987;40:1129-33.